GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut. Show more
North Tower, Stamford, CT, 06902, United States
Start AI Chat
Market Cap
2.517B
52 Wk Range
$55.17 - $170.87
Previous Close
$87.08
Open
$84.02
Volume
1,141,442
Day Range
$80.15 - $85.34
Enterprise Value
3.351B
Cash
155.1M
Avg Qtr Burn
N/A
Insider Ownership
13.38%
Institutional Own.
-
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
